
Regulation Policy | |
CSE Analysis: Another Case of FDA Delay And Censorship |
A recent case shows Food and Drug Administration censorship still denies consumers
potentially lifesaving information, and the FDA illegally delays action, claim critics. In this
instance, consumers were denied information about a food supplement that can lower their
cholesterol levels, and thus the risk of heart disease, for nine years. On February 18, 1998, the FDA announced it will allow foods containing soluble fiber
from the husk of psyllium (silly-um) seeds, such as breakfast cereals and dietary
supplements, to advertise their ability to lower the risk of coronary heart disease (CHD).
CHD is America's number one killer, causing or contributing to more than 750,000 deaths
each year. And more than half of American adults have borderline or high cholesterol
levels which contribute to CHD. Beginning with a 1989 report in Journal of the American Medical Association
(JAMA) studies have found psyllium may reduce the risk of CHD by lowering blood
cholesterol levels. However, food producers cannot give consumers information about
health claims until the FDA approves.
Consumers and taxpayers have a right to know if the FDA is not doing its job, say critics. And when it approves a health claim, the FDA should disclose how long it suppressed that information. Source: Michael F. Cannon, "The FDA Should Come Clean: Consumers Have a Right to Know How Long the FDA Hid Psyllium's Ability to Fight Heart Disease," Capitol Comment No. 186, May 13, 1998, Citizens for a Sound Economy Foundation, 1250 H Street, N.W., Suite 700, Washington, D.C. 20005, (202) 783-3870. For text http://www.cse.org/cc186-csef-health.htm |
Home | Support Us | All Issues | Social Security | Debate Central | Contact Us
Dallas Headquarters: 12770 Coit Rd., Suite 800 - Dallas, TX 75251-1339 - 972/386-6272 - Fax 972/386-0924
Washington Office: 601 Pennsylvania Ave. NW, Suite 900 South Building - Washington, DC 20004 - 202/220-3082 - Fax 202/220-3096
© 2001 NCPA